| Title： | Diagnostic Criteria for Traditional Chinese Medicine Syndromes of Cardiac Toxicity Events in Breast Cancer Patients |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Diagnosis |
| Countries and regions： | China |
| Guidelines users： | Physicians of traditional Chinese medicine, western medicine, and integrated traditional Chinese and western medicine |
| Evidence classification method： | Grading of recommendations assessment, development and evaluation（GRADE）. And considering the special nature of TCM syndromes and the importance of expert recognition, adjustments will be made in conjunction with the level of expert endorsemen. |
| Development unit： | Cardiovascular Disease Branch of China Association of Chinese Medicine,Shanghai Association of Traditional Chinese Medicine for Breast Diseases, and Longhua Hospital Affiliated with Shanghai University of Traditional Chinese Medicine. |
| Registration time: | 2024-10-23 |
| Registration number： | PREPARE-2024CN905 |
| Purpose of the guideline: | n patients with breast cancer, especially those with the risk of cardiovascular diseases, forming an expert consensus on the diagnostic standards of TCM syndrome is crucial for guiding clinical medical workers to identify the risk of cardiac toxicity, optimize anti-tumor treatment plans, and improve patient treatment compliance and quality of life. This consensus not only enhances patient treatment compliance and quality of life but also promotes multidisciplinary treatment team (MDT) collaboration, strengthens information sharing and collaborative work among physicians of different specialties, thereby improving treatment outcomes and advancing medical progress. The consensus on TCM syndrome diagnostic standards is of great significance for the treatment of breast cancer. It helps to improve the specificity and effectiveness of treatment, reduce adverse reactions, improve the quality of life for patients, and provide a reference for the prognosis assessment of populations at risk of breast cancer-related cardiac toxicity events. In addition, the formulation of the consensus provides standardized assessment tools for clinical research, enhancing the quality and reliability of research. |
Latest registration
